vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-936Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL OBSERVATIONSЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ПРОЛОНГИРОВАННОЙ ТЕРАПИИ ЦИКЛОСПОРИНОМ ДЕТЕЙ С ФОКАЛЬНО-СЕГМЕНТАРНЫМ ГЛОМЕРУЛОСКЛЕРОЗОМEFFICACY AND SAFETY OF PROLONGED TREATMENT WITH CYCLOSPORINE IN CHILDREN WITH FOCAL SEGMENTAL GLOMERULOSCLEROSISКомароваО.В.KomarovaO.V.МатвееваМ.В.MatveevaM.V.ЦыгинА.Н.TsyginA.N.ЛеоноваЛ.В.LeonovaL.V.ТимофееваА.Г.TimofeevaA.G.Научный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowRussian Federation20101609201594Вопросы современной педиатрии155159Copyright © Комарова О., Матвеева М., Цыгин А., Леонова Л., Тимофеева А., 20102010Комарова О., Матвеева М., Цыгин А., Леонова Л., Тимофеева А.Komarova O., Matveeva M., Tsygin A., Leonova L., Timofeeva A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/936ReferencesTroyanov St., Wall C.A., Miller J.A., et al. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J. Am. Soc. Nephrol. 2005; 16: 1061–1068.Troyanov St., Wall C.A., Miller J.A., et al. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J. Am. Soc. Nephrol. 2005; 16: 1061–1068.Braden G.L., Mulhern J.G., O'Shea M.H. et al. Changing incidence of glomerular diseases in adults. Am. J. Kidney Dis. 2000; 35 (5): 878–883.Braden G.L., Mulhern J.G., O'Shea M.H. et al. Changing incidence of glomerular diseases in adults. Am. J. Kidney Dis. 2000; 35 (5): 878–883.Ichikawa I., Fogo A. Focal segmental glomerulosclerosis. Pediatr. Nephrol. 1996; 10 (3): 347–391.Ichikawa I., Fogo A. Focal segmental glomerulosclerosis. Pediatr. Nephrol. 1996; 10 (3): 347–391.Korbet S.M. Treatment of primary focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 2002; 62: 2301–2310.Korbet S.M. Treatment of primary focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 2002; 62: 2301–2310.Lieberman K.V., Tejani A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant focal segmental glomerulosclerosis in children. J. Am. Soc. Nephrol. 1996; 7 (1): 56–63.Lieberman K.V., Tejani A. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant focal segmental glomerulosclerosis in children. J. Am. Soc. Nephrol. 1996; 7 (1): 56–63.Ehrich J.H., Pape L., Schiffer M. Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis: an update of treatment options for children. Paediatr. Drugs. 2008; 10 (1): 9–22.Ehrich J.H., Pape L., Schiffer M. Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis: an update of treatment options for children. Paediatr. Drugs. 2008; 10 (1): 9–22.Rydel J.J., Korbet S.M., Borok R.Z., Schwartz M.M. Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment. Am. J. Kidney Dis. 1995; 25: 534.Rydel J.J., Korbet S.M., Borok R.Z., Schwartz M.M. Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment. Am. J. Kidney Dis. 1995; 25: 534.Meyrier A., Simon P., Perret G., Condamin-Meyrier M.C. Remission of idiopathic nephrotic syndrome after treatment with cyclosporine. Ann. Br. Med. J. 1986; 292: 789–792.Meyrier A., Simon P., Perret G., Condamin-Meyrier M.C. Remission of idiopathic nephrotic syndrome after treatment with cyclosporine. Ann. Br. Med. J. 1986; 292: 789–792.Suthanthiran M., Strom T.B. Immunoregulatory drugs: mechanistic basis for use in organ transplantation. Pediatr. Nephrol. 1997. 11(5): 651–657.Suthanthiran M., Strom T.B. Immunoregulatory drugs: mechanistic basis for use in organ transplantation. Pediatr. Nephrol. 1997. 11(5): 651–657.Scheinman R.I., Cogswell P.G., Lofquist A.K., Baldwin A.S. Role of transcription activation of Iβα in mediation of immunosupression by glucocorticoids. Sience. 1995; 270: 283–286.Scheinman R.I., Cogswell P.G., Lofquist A.K., Baldwin A.S. Role of transcription activation of Iβα in mediation of immunosupression by glucocorticoids. Sience. 1995; 270: 283–286.Tune B.M., Mendoza S.A. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. J. Am. Soc. Nephrol. 2001; 12: 44–47.Tune B.M., Mendoza S.A. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. J. Am. Soc. Nephrol. 2001; 12: 44–47.Комарова О.В., Цыгин А.Н., Леонова Л.В. и др. Терапия циклосоприном А у детей с фокальносегментарным гломерулосклерозом. Вопросы современной терапии. 2009; 8(5): 93–97.Комарова О.В., Цыгин А.Н., Леонова Л.В. и др. Терапия циклосоприном А у детей с фокальносегментарным гломерулосклерозом. Вопросы современной терапии. 2009; 8(5): 93–97.Joshua Y., Kausma A., Kitching R. A New approach to idiopathic nephrotic syndrome. J. Am. Soc. Nephrol. 2007; 18: 2621–2622.Joshua Y., Kausma A., Kitching R. A New approach to idiopathic nephrotic syndrome. J. Am. Soc. Nephrol. 2007; 18: 2621–2622.Klein M., Radhakrishnan J., Appel G. Cyclosporine treatment of glomerular diseases. Ann. Rev. Med. 1999; 50: 1–15.Klein M., Radhakrishnan J., Appel G. Cyclosporine treatment of glomerular diseases. Ann. Rev. Med. 1999; 50: 1–15.Цыгин А.Н., Комарова О.В., Сергеева Т.В. и др. Нефротический синдром. Клинические рекомендации по педиатрии. Под ред. А.А. Баранова. М.: Геотар–Медиа. 2005; 107-128.Цыгин А.Н., Комарова О.В., Сергеева Т.В. и др. Нефротический синдром. Клинические рекомендации по педиатрии. Под ред. А.А. Баранова. М.: Геотар–Медиа. 2005; 107-128.Kveder R. Therapy-resistant focal and segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2003; 18 (Suppl. 5): 34–37.Kveder R. Therapy-resistant focal and segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2003; 18 (Suppl. 5): 34–37.Niaudet P. Treatment of childhood steroid resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J. Pediatr. 1994; 125 (6): 981–986.Niaudet P. Treatment of childhood steroid resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J. Pediatr. 1994; 125 (6): 981–986.Waldo F.B., Benfield M.R., Kohaut E.C. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr. Nephrol. 2009; 12(5): 397–400.Waldo F.B., Benfield M.R., Kohaut E.C. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr. Nephrol. 2009; 12(5): 397–400.Burgess E. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int. Suppl. 1999; 70: 26–32.Burgess E. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int. Suppl. 1999; 70: 26–32.El-Husseini A., El-Basuony F., Mahmoud I. et al. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrol. Dial. Transplant. 2005; 20(11): 2433–2438.El-Husseini A., El-Basuony F., Mahmoud I. et al. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrol. Dial. Transplant. 2005; 20(11): 2433–2438.Meyrier A., Noel L.H., Auriche P., Callard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int. 1994; 45 (5): 1446–1456.Meyrier A., Noel L.H., Auriche P., Callard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int. 1994; 45 (5): 1446–1456.

The authors declare that there are no conflicts of interest present.